Expert Column

 
 
  • Klebsiella pneumoniae Carbapenemase: Extended-Spectrum beta-Lactamase The emergence of KPC resistance is a major threat to global health. Review the latest information here.
  • Clostridium difficile Infection: A Global Perspective of an Epidemic Why is there a global epidemic of CDI, and how can it be controlled?
  • CA-MRSA Infections: Changes in Practice Required? CA-MRSA incidence is on the rise. Accurate early diagnosis and appropriate management are key factors in improving patient outcomes.
  • Climate Change and Infectious Diseases A changing climate affects not only the burden of infectious diseases, but also the interrelationships of those sectors responsible for reducing that burden.
  • Infectious Syphilis Epidemic An infectious syphilis epidemic returns to challenge public health. As past becomes present, what do clinicians need to know about this sexually transmitted infection?
  • Pandemic Influenza Transmission Can we predict whether the next pandemic will be like the mild 1968 Hong Kong influenza or more similar to the devastating 1918 pandemic, which may have killed more than 50 million people worldwide?
  • Influenza Vaccination for Adolescent and Colllege Healthcare Why should influenza immunization of low-risk populations be considered? A successful university health campaign underscores the impact to public health.
  • Dark Clouds on the Horizon Innovative pharmacologic prevention and treatment options for pandemic influenza provide hope to global health community.
  • Healthcare Worker Influenza Immunization Despite local and national efforts to encourage influenza vaccination, the overall vaccination rate among US healthcare workers remains unacceptably low. What can be done to improve rates?
  • Preparing for the Next Influenza Pandemic Was the Great Plague of Athens (ca. 430 BC) the first recorded influenza pandemic? Was the SARS outbreak of 2003 the latest warning? Could avian influenza H5N1 virus usher the next influenza pandemic?
  • Will CCR5 Inhibitors Overcome Development Obstacles? This drug class represents the first major attempt by pharma to directly target a cellular rather than a viral moiety as a means of interfering with viral replication.
  • Patient Counseling in Genital Herpes Read this Expert Column concerning key counseling messages for patients with genital herpes and their sexual partners.
  • Importance of Testing and Diagnosis in Genital Herpes Herpes simplex virus, the most prevalent sexually transmitted infection, is often asymptomatic and therefore difficult to diagnose. Dr. Morrow discusses the laboratory tests used to detect the virus.
  • Asymptomatic HSV-2 Shedding Asymptomatic viral shedding of HSV-2 is the driving force behind the spread of genital herpes. Dr. Peter Leone examines HSV-2 transmission and the role of antiviral therapy in its prevention.
  • Preventing Sexual Transmission of Genital Herpes Preventing the spread of genital herpes has become one of medicine's top priorities. Lawrence Corey, MD, explains how recent discoveries have yielded new means of combatting 2 global epidemics.
  • Rescreening for Chlamydial Infection and Gonorrhea Over the past decade, changes in the epidemiology of bacterial STDs have provided an impetus for reconsidering rescreening in specific groups.
  • The Return of the Gonococcus If quinolones become an unreliable treatment for gonorrhea throughout the US and if cefixime production is permanently discontinued, there won't be reliable oral treatment.
  • Herpes and HIV: New Advice from the CDC Most of the substantive changes in the CDC's new STD Treatment Guidelines 2002 relate to the transmission and antiviral treatment of herpes simplex virus and HIV.